Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

LMBBearishLegalnews

High materiality7/10

Limbach lowers 2026 EBITDA guidance; shares slide amid investigation risk

Aug 6, 2026, 1:47 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Immediate revenue guidance downgrade and a quarterly miss pressure the stock; added legal risk from the investigation increases downside protection for a period, as investors await clarity on any potential liabilities and remediation actions.

AI summary

What happened, with direct paths to the underlying reporting

Limbach reaffirmed FY2026 EBITDA guidance of $90–$94M in May, but on Aug 4 cut it to $78–$84M after a weak Q2, sending the stock lower. Q2 EBITDA was $13.9M with adjusted EPS of $0.64 vs consensus $0.93–$0.94, signaling weakness in project timing and price sensitivity. Separately, SueWallSt. disclosed a securities investigation into potential misstatements, adding legal uncertainty to LMB’s near-term outlook.

May 2026: Limbach reaffirmed FY2026 EBITDA guidance of $90–$94M.
Aug 4, 2026: guidance cut to $78–$84M; shares fell.
Q2 2026 EBITDA: $13.9M; adjusted EPS $0.64 vs consensus $0.93–$0.94.
Management cited project timing and price sensitivity for the cut.
SueWallSt. announces pending securities investigation into potential misstatements.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.